Join 2,700+ biotech and pharma professionals who start their morning with the deals, trials, and decisions shaping the industry.
No spam. Unsubscribe anytime.
What lands in your inbox
Curated, not aggregated. Only what matters.
M&A, trials, FDA decisions, funding โ what moves the market.
Not AI summaries. Human curation from someone in the industry.
Never miss a deal or decision.
biotech & pharma professionals subscribe
Anis Fahandej-Sadi
M.Sc. Chemistry ยท Ex-Cytiva ยท Ex-OmniaBio
Free. Daily. Actually useful.